...
首页> 外文期刊>Organic & biomolecular chemistry >Synthesis and biological evaluation of hybrids from farnesylthiosalicylic acid and hydroxylcinnamic acid with dual inhibitory activities of Ras-related signaling and phosphorylated NF-κB
【24h】

Synthesis and biological evaluation of hybrids from farnesylthiosalicylic acid and hydroxylcinnamic acid with dual inhibitory activities of Ras-related signaling and phosphorylated NF-κB

机译:法呢基硫代水杨酸和羟基肉桂酸杂交体的合成及生物学评价,具有Ras相关信号和磷酸化NF-κB双重抑制活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of hybrids (5a-r) of farnesylthiosalicylic acid (FTS) and hydroxylcinnamic acid were designed and synthesized. Most of the hybrids displayed potent antiproliferative activity against seven cancer cell lines in vitro, superior to FTS as well as sorafenib. The most potent compound 5f selectively inhibited cancer cells but not non-tumor liver cell proliferation in vitro, and significantly induced SMMC-7721 cell apopto-sis. Interestingly, 5f could simultaneously inhibit not only Ras-related signaling but also phosphorylated NF-κB, which may synergetically contribute to the cell growth inhibition and apoptosis induction. Moreover, 5f showed low acute toxicitv to mice and significantly inhibited the hepatoma tumor growth.
机译:设计并合成了一系列法呢基硫代水杨酸(FTS)和羟基肉桂酸的杂化物(5a-r)。大多数杂种在体外对七种癌细胞系均表现出强大的抗增殖活性,优于FTS和索拉非尼。最有效的化合物5f在体外选择性抑制癌细胞,但不抑制非肿瘤肝细胞增殖,并显着诱导SMMC-7721细胞凋亡。有趣的是,5f不仅可以同时抑制与Ras相关的信号传导,而且还可以抑制磷酸化的NF-κB,这可能协同作用于细胞生长抑制和凋亡诱导。此外,5f对小鼠的急性毒性较低,并显着抑制了肝癌肿瘤的生长。

著录项

  • 来源
    《Organic & biomolecular chemistry》 |2014年第25期|4517-4530|共14页
  • 作者单位

    School of Pharmacy, Nantong University, Nantong, 226001, PR China ,State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China;

    School of Pharmacy, Nantong University, Nantong, 226001, PR China ,State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China;

    School of Pharmacy, Nantong University, Nantong, 226001, PR China;

    School of Pharmacy, Nantong University, Nantong, 226001, PR China;

    School of Pharmacy, Nantong University, Nantong, 226001, PR China;

    School of Pharmacy, Nantong University, Nantong, 226001, PR China;

    State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China ,Center of Drug Discovery, China Pharmaceutical University, Nanjing, 210009, PR China;

    State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China ,Center of Drug Discovery, China Pharmaceutical University, Nanjing, 210009, PR China;

    State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China ,Center of Drug Discovery, China Pharmaceutical University, Nanjing, 210009, PR China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号